Stay updated on TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial

Sign up to get notified when there's something new on the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:17:01.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added glossary visibility, updated labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and updated the revision to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:41:25.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed. There is no impact on the study page's content or how users interact with it.
    Difference
    0.1%
    Check dated 2026-01-14T01:22:50.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Added a new Locations section listing North Carolina and Tennessee for trial sites. Removed the separate North Carolina Locations and Tennessee Locations sections.
    Difference
    0.3%
    Check dated 2025-12-23T12:30:09.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the page, indicating a minor site update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T21:17:27.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The notice about government funding and NIH operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T18:35:57.000Z thumbnail image

Stay in the know with updates to TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page.